Glazer Capital LLC’s Tourmaline Bio TRML Stock Holding History

Glazer Capital LLC’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-180,155	Closed	-$8.62M	–	406
2025 Q3	$8.62M	Buy	+180,155	New	+$5M	0.29%	85

Glazer Capital LLC's TRML Position: Q4 2025 in Review

Glazer Capital LLC sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 180,155 shares — an estimated $8.62M sold.

Glazer Capital LLC first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $8.62M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Glazer Capital LLC reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Glazer Capital LLC sold 180,155 Tourmaline Bio shares in Q4 2025, an estimated $8.62M.
Glazer Capital LLC first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
Glazer Capital LLC's Tourmaline Bio position peaked at $8.62M in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Glazer Capital LLC's 13F filing for Q4 2025, filed 13 Feb 2026.